Aug 29, 2023 | Infection Control, News
Vaxess Technologies, Inc., a life sciences company developing a shelf-stable vaccine patch with potential for self-application, announced that it is collaborating with AstraZeneca for the evaluation of an RNA-based pandemic influenza prototype vaccine in patch format.... 
Aug 29, 2023 | Covid-19, News
The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and... 
Aug 22, 2023 | Infection Control, News
The US Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in... 
Jul 26, 2023 | Covid-19, Infection Control, News
A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19. In this study, the authors...
